Food Allergy Center at MGH, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts.
Food Allergy Center at MGH, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Food Allergy Science Initiative at the Broad Institute, Cambridge, Massachusetts; Division of Pediatric Allergy & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Ann Allergy Asthma Immunol. 2023 Sep;131(3):362-368.e1. doi: 10.1016/j.anai.2023.05.019. Epub 2023 May 25.
There are conflicting associations reported between food allergies (FAs) and poor growth, with some indication that children with multiple FAs are at highest risk.
We analyzed longitudinal weight-for-length (WFL) trajectories from our healthy cohort to evaluate growth in children with IgE-mediated FAs and food protein-induced allergic proctocolitis (FPIAP), a non-IgE-mediated FA.
Our observational cohort of 903 healthy newborn infants was prospectively enrolled to evaluate the development of FAs. Longitudinal mixed effects modeling was used to compare differences in WFL among children with IgE-FA and FPIAP, compared with unaffected children, through age 2.
Among the 804 participants who met inclusion criteria, FPIAP cases had significantly lower WFL than unaffected controls during active disease, which resolved by 1 year of age. In contrast, children with IgE-FA had significantly lower WFL than unaffected controls after 1 year. We also found that children with IgE-FA to cow's milk had significantly lower WFL over the first 2 years of age. Children with multiple IgE-FAs had markedly lower WFL over the first 2 years of age.
Children with FPIAP have impaired growth during active disease in the first year of age which resolves, whereas children with IgE-FA, particularly those with multiple IgE-FA, have impaired growth more prominently after the first year of age. It may be appropriate to focus nutritional assessment and interventions accordingly during these higher risk periods in these patient populations.
食物过敏(FA)与生长不良之间存在相互矛盾的关联,有迹象表明,患有多种 FA 的儿童风险最高。
我们分析了来自健康队列的纵向体重-身长(WFL)轨迹,以评估 IgE 介导的 FA 和食物蛋白诱导的过敏直肠炎(FPIAP)患儿的生长情况,FPIAP 是非 IgE 介导的 FA。
我们前瞻性地招募了 903 名健康新生儿的观察队列,以评估 FA 的发展。通过年龄 2 岁时的纵向混合效应模型,比较 IgE-FA 和 FPIAP 患儿与无 FA 儿童之间的 WFL 差异。
在符合纳入标准的 804 名参与者中,FPIAP 病例在疾病活跃期的 WFL 明显低于无 FA 对照组,1 岁时疾病缓解。相比之下,1 岁后 IgE-FA 患儿的 WFL 明显低于无 FA 对照组。我们还发现,对牛奶 IgE-FA 的儿童在头 2 年的 WFL 明显较低。对多种 IgE-FA 的儿童在前 2 年的 WFL 明显较低。
FPIAP 患儿在 1 岁以内的疾病活跃期生长不良,疾病缓解,而 IgE-FA 患儿,尤其是对多种 IgE-FA 的儿童,在 1 岁以后的生长不良更为明显。在这些高危期,针对这些患者群体,可能需要相应地关注营养评估和干预。